Veterinary pharmaceuticals firm Dechra has announced the expansion of its range of products to treat otitis externa with the introduction of Osurnia.
You'll need to
subscribe to unlock this content. Already subscribed? Login?
Become a member for unlimited access
Remove all content restrictions with a membership account. First-year special offer pricing. Cancel any time.
You have read 2/2 free articles this month.
Person
Monthly
£4.99
Yearly
£49.99
Save £9.89
No, thanks
I already have an account
